REFERENCES
- Bauer , G. , Dao , M. A. Case , S. S. 2008 . In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors . Molecular Therapy , 16 : 1308 – 1315 .
- Caplan , A. I. 2009 . Why are MSCs therapeutic? New data: New insight . Journal of Pathology , 217 : 318 – 324 .
- Dey , N. D. , Bombard , M. C. Roland , B. P. 2010 . Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease . Behavioural Brain Research , 214 : 193 – 200 .
- Hess , P. 2012 . Intracranial stem cell-based transplantation: Reconsidering the ethics of phase 1 clinical trials in light of irreversible interventions in the brain . AJOB Neuroscience , 3 ( 2 ) : 3 – 13 .
- Joyce , N. , Annett , G. , Wirthlin , L. , Olson , S. , Bauer , G. and Nolta , J. A. 2010 . Mesenchymal stem cells for the treatment of neurodegenerative disease . Regenerative Medicine , 5 : 933 – 946 .
- Matthews , D. J. , Sugarman , J. Bok , H. 2008 . Cell-based interventions for neurologic conditions: Ethical challenges for early human trials . Neurology , 71 : 288 – 293 .
- Meyerrose , T. , Olson , S. Pontow , S. 2010 . Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors . Advanced Drug Delivery Reviews , 62 : 1167 – 1174 .
- Neuralstem, Inc. 2011 . First patient dosed in cervical region in Neuralstem ALS stem cell trial. Press release . Available at: http://investor.neuralstem.com/phoenix.zhtml?c = 203908&p = irol-newsArticle_print&ID = 1633337&highlight = (accessed January 10, 2012)
- Olson , S. D. , Kambal , A. Pollock , K. 2011 . Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin . Molecular and Cellular Neurosciences , 49 ( 3 ) : 271 – 281 .
- Olson , S. D. , Pollock , K. Kambal , A. 2012 . Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease . Molecular Neurobiology , 45 ( 1 ) : 87 – 98 .
- Sea , K. , Gowing , G. Joyce , N. 2011 . ALS in California: A report from the First Annual California ALS Research Summit . Neurodegenerative Disease Management , 1 : 281 – 284 .
- Tolar , J. , Villeneuve , P. and Keating , A. 2011 . Mesenchymal stromal cells for graft-versus-host disease . Human Gene Therapy , 22 : 257 – 262 .
- Yarborough , M. and Sharp , R. R. 2009 . Public trust and research a decade later: What have we learned since Jesse Gelsinger's death? . Molecular Genetics and Metabolism , 97 ( 1 ) : 4 – 5 .
- Zhang , Z. X. , Guan , L. X. , Zhang , K. , Zhang , Q. and Dai , L. J. 2008 . A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury . Cytotherapy , 10 ( 2 ) : 134 – 139 .